Roman Butler Fullerton & Co. Makes New $208,000 Investment in Kimberly-Clark Co. (NYSE:KMB)

Roman Butler Fullerton & Co. acquired a new stake in Kimberly-Clark Co. (NYSE:KMB) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 1,481 shares of the company’s stock, valued at approximately $208,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in KMB. Price T Rowe Associates Inc. MD grew its stake in shares of Kimberly-Clark by 19.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 5,893,146 shares of the company’s stock worth $762,279,000 after acquiring an additional 944,920 shares during the last quarter. Norges Bank bought a new stake in Kimberly-Clark during the 4th quarter valued at approximately $437,420,000. Capital World Investors raised its stake in Kimberly-Clark by 17.8% during the 1st quarter. Capital World Investors now owns 2,269,492 shares of the company’s stock valued at $293,559,000 after purchasing an additional 342,790 shares during the period. Nordea Investment Management AB grew its holdings in Kimberly-Clark by 2.9% during the 1st quarter. Nordea Investment Management AB now owns 1,720,051 shares of the company’s stock valued at $222,093,000 after buying an additional 48,103 shares in the last quarter. Finally, ProShare Advisors LLC grew its holdings in Kimberly-Clark by 9.8% during the 1st quarter. ProShare Advisors LLC now owns 1,487,835 shares of the company’s stock valued at $192,451,000 after buying an additional 132,576 shares in the last quarter. Institutional investors own 76.29% of the company’s stock.

Kimberly-Clark Stock Performance

NYSE KMB traded up $0.14 during mid-day trading on Tuesday, reaching $138.44. 1,777,080 shares of the stock were exchanged, compared to its average volume of 2,191,301. The company has a debt-to-equity ratio of 5.59, a quick ratio of 0.58 and a current ratio of 0.85. The company has a market capitalization of $46.61 billion, a P/E ratio of 25.42, a P/E/G ratio of 2.95 and a beta of 0.37. Kimberly-Clark Co. has a 1 year low of $116.32 and a 1 year high of $145.62. The business’s 50 day moving average is $139.32 and its 200-day moving average is $131.53.

Kimberly-Clark (NYSE:KMB) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $1.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.25. The business had revenue of $5.03 billion for the quarter, compared to the consensus estimate of $5.10 billion. Kimberly-Clark had a net margin of 11.28% and a return on equity of 223.55%. The company’s revenue was down 2.0% compared to the same quarter last year. During the same period last year, the firm posted $1.65 earnings per share. On average, equities research analysts forecast that Kimberly-Clark Co. will post 7.21 EPS for the current fiscal year.

Kimberly-Clark Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 2nd. Stockholders of record on Friday, September 6th will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.52%. The ex-dividend date is Friday, September 6th. Kimberly-Clark’s dividend payout ratio (DPR) is 89.71%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on KMB. Deutsche Bank Aktiengesellschaft boosted their price objective on Kimberly-Clark from $139.00 to $142.00 and gave the company a “hold” rating in a report on Wednesday, July 24th. Royal Bank of Canada restated an “outperform” rating and set a $165.00 price target on shares of Kimberly-Clark in a research note on Wednesday, July 24th. Barclays cut their price target on shares of Kimberly-Clark from $136.00 to $135.00 and set an “equal weight” rating on the stock in a research note on Friday, July 19th. Wells Fargo & Company cut their price target on shares of Kimberly-Clark from $138.00 to $134.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 24th. Finally, Argus upgraded shares of Kimberly-Clark to a “hold” rating in a research note on Friday, July 26th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $145.67.

Insider Activity

In related news, insider Jeffrey P. Melucci sold 37,699 shares of the firm’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the completion of the sale, the insider now directly owns 19,935 shares in the company, valued at $2,819,207.70. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other Kimberly-Clark news, insider Jeffrey P. Melucci sold 37,699 shares of the stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the completion of the transaction, the insider now owns 19,935 shares of the company’s stock, valued at $2,819,207.70. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Gonzalo Uribe sold 1,780 shares of the stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $140.84, for a total transaction of $250,695.20. Following the transaction, the insider now directly owns 7,377 shares of the company’s stock, valued at approximately $1,038,976.68. The disclosure for this sale can be found here. Company insiders own 0.62% of the company’s stock.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.